JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 90 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,761,000 | +367.1% | 201,746 | +78.1% | 0.05% | +444.4% |
| Q3 2019 | $377,000 | -45.0% | 113,248 | -18.1% | 0.01% | -40.0% |
| Q2 2019 | $685,000 | -14.9% | 138,330 | +6.6% | 0.02% | -16.7% |
| Q1 2019 | $805,000 | +466.9% | 129,789 | +207.3% | 0.02% | +350.0% |
| Q4 2018 | $142,000 | -85.3% | 42,231 | -42.4% | 0.00% | -81.0% |
| Q4 2017 | $966,000 | +4.2% | 73,311 | +23.1% | 0.02% | +16.7% |
| Q3 2017 | $927,000 | +24.1% | 59,540 | +11.9% | 0.02% | +20.0% |
| Q2 2017 | $747,000 | – | 53,212 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |